Cyclopharm Limited - Ordinary Fully Paid Deferred

Century Australia Investments Limited

Cyclopharm Ltd. is a radiopharmaceutical company, which engages in the diagnostic imaging in lung health. The firm specializes in functional lung ventilation imagery. The principal activities of the Company include manufacture and sale of medical equipment and radiopharmaceuticals, including associated research and development and distribution of third-party products to the diagnostic imaging sector. Its segments include Technegas and Molecular Imaging. The Technegas segment is a supplier of diagnostic equipment and consumables used by physicians in the detection of pulmonary embolism and a distributor of third-party products to the diagnostic imaging sector. The Molecular Imaging segment produces radiopharmaceuticals to be used by physicians in the detection of cancer, neurological disorders, and cardiac disease. The company distributes its products under the name Technegas in over 60 countries across the world with approximately 1500 nuclear medicine departments. The company also focuses on commercializing its Ultralute technology.

Cyclopharm Ltd

Health Care Equipment & Supplies - 351010

Cyclopharm Limited

Telix Pharmaceuticals Ltd. engages in the development and commercialization of several clinical-stage oncology assets. The company is headquartered in Melbourne, Victoria and currently employs 234 full-time employees. The company went IPO on 2017-11-15. In MTR therapy, a radionuclide is attached to a targeting agent such as a small molecule or antibody. This targeting agent specifically binds to tumors and delivers a radioactive payload in a selective way. The radioactive payload can either be diagnostic (for imaging) or therapeutic, or both. The Company’s lead programs include TLX591-CDx (Illuccix) / TLX591 for diagnosis and treatment of metastatic castrate-resistant prostate cancer, TLX250-CDx/TLX250 for diagnosis and treatment of renal (kidney) cancer, TLX101-CDx / TLX101 for diagnosis and treatment of glioblastoma (brain cancer), and TLX66-CDx (Scintimun) / TLX66 for the treatment of bone marrow conditioning and rare diseases.

Development and commercialising molecularly targeted radiation products for the treatment of cancer.

Telix Pharmaceuticals Limited

VAS.AX was created on 2009-05-04 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard Australian Shares Index ETF seeks to track the return of the S&P/ASX 300 Index before taking into account fees, expenses and tax.

Vanguard Australian Shares Index ETF (ASX: VAS) seeks to track the performance of the ASX 300 index before account fees, expenses, and taxes. The index tracks the top 300 companies on the Australian Securities Exchange (ASX). These are mostly large and established Australian companies. It is a popular choice among passive individual investors who don't have the time or the expertise to actively invest in stocks.

Vanguard Australian Shares Index Etf

Lynas Rare Earths Ltd. engages in the production of rare earth minerals. The company is headquartered in Kuantan, Pahang.  The Company’s assets include Mt Weld, Lynas Malaysia, Kalgoorlie and Lynas USA. Mt Weld is a rare earth mine, located approximately 35-kilometer (km) south of Laverton in Western Australia. Lynas Malaysia is an integrated manufacturing facility, separating and processing rare earths materials, located in the Gebeng Industrial Estate near the Port of Kuantan in Malaysia. Kalgoorlie is a rare earth processing facility, which is located in the Western Australia. Its subsidiaries include Lynas Malaysia Sdn Bhd, Lynas Services Pty Ltd, Mount Weld Holdings Pty Ltd, Mount Weld Mining Pty Ltd, and Lynas Kalgoorlie Pty Ltd.

Production of Rare Earths concentrate at Mt Weld. Production and sale of Rare Earths products from the LAMP in Malaysia.

Lynas Rare Earths Limited

IVV.AX was created on 2000-05-15 by iShares. The fund's investment portfolio concentrates primarily on large cap equity. The Fund aims to provide investors with the performance of an index, before fees and expenses. The index is designed to measure the performance of large capitalisation US equities.

The iShares S&P 500 ETF seeks to track the investment results of an index composed of large-capitalisation U.S. equities.

iShares S&P 500 Etf

ESGI.AX was created on 2018-03-06 by VanEck. The fund's investment portfolio concentrates primarily on total market equity. The Fund aims to provide investment returns before fees and other costs which track the performance of its Reference Index in Australian dollars.

VanEck Vectors MSCI International Sustainable Equity ETF (ESGI) gives investors exposure to a diversified portfolio of sustainable international companies listed on exchanges in developed markets around the world (ex Australia). ESGI aims to provide investment returns before fees and other costs which track the performance of the Index.

A2B Australia Ltd. engages in the provision of taxi charge account and related services to the taxi industry. The company is headquartered in Alexandria, New South Wales.  The firm provides taxi network services to taxi operators and drivers nationally in Australia. Its network services include taxi booking services, full taxi fit outs and repairs, vehicle financing and insurance, as well as driver training and education. The Company’s mobility Services are provided under brands, including 13cabs, Silver Service and Maxi Taxi. The company provides integrated booking, payment and safety technologies to taxi and private hire businesses under brands, including Cabcharge and Mobile Technologies International. Its Cabcharge provides payment terminals enabling drivers to process non-cash trip payments. Its Mobile Technologies International provides a vehicle monitoring platform. The firm also provides payment consulting, software, processing and terminals under brands, including EFT Solutions, Spotto, Giraffe and FlamingoPay.

A2B Australia Limited

ARN Media Ltd is a AU-based company operating in Media industry. The company is headquartered in Macquarie, New South Wales.  ARN Media Limited, formerly HT&E Limited, is an Australia-based broadcast and on-demand audio company. The firm owns approximately 58 radio stations across 33 markets plus 46 digital audio broadcasting (DAB+) stations nationwide. The firm's portfolio of brands includes KIIS Network, Pure Gold Network, CADA, Regional, iHeartRadio, and iHeartPodcast Network. KIIS Network includes KIIS stations, KIIS 1065, KIIS 101.1, and KIIS 97.3. Pure Gold Network delivers a combination of music, intelligent content and timeless entertainment to the Gen X audience. Its digital entertainment platform iHeartRadio app is an all-in-one radio, music streaming, podcast, and live events platform available to Australians in every state. Audiences can also access their favorite stations in Australia from ARN, Special Broadcasting Service (SBS) and stations from New Zealand and the United States. Its iHeartPodcast Network Australia is the preeminent podcast destination for creators, brands and audiences.

Arn Media Limited

A200.AX was created on 2018-05-07 by BetaShares. The fund's investment portfolio concentrates primarily on large cap equity. The ETF currently has 2975.21m in AUM and 200 holdings. A200.AX aims to track the performance of an index (before fees and expenses) comprising 200 of the largest companies by market capitalisation listed on the ASX.

BetaShares Australia 200 ETF

Vanguard Australian Shares Index ETF seeks to track the return of the S&P/ASX 300 Index before taking into account fees, expenses and tax.

VGS.AX was created on 2014-11-18 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard MSCI International Shares Index ETF seeks to track the return of the MSCI World ex-Australia Index (with net dividends reinvested) in Australian dollars before taking into account fees, expenses and tax.

Vanguard MSCI Index International Shares Etf

VDHG.AX was created on 2017-11-20 by Vanguard. The fund's investment portfolio concentrates primarily on target outcome asset allocation. Vanguard Diversified High Growth Index ETF seeks to track the weighted average return of the various indices of the underlying funds in which it invests, in proportion to the Strategic Asset Allocation, before taking into account fees, expenses and tax.

Vanguard Diversified High Growth Index ETF seeks to track the weighted average return of the various indices of the underlying funds in which it invests, in proportion to the Strategic Asset Allocation, before taking into account fees, expenses and tax.

VTS.AX was created on 2009-05-12 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard U.S. Total Market Shares Index ETF seeks to track the performance of the CRSP US Total Market Index, providing investors with exposure to a broadly diversified collection of securities that, in the aggregate, approximates the full index in terms of key characteristics.

Compare AU

Compare CYC vs. A200

Overview

Performance

Industry & Region

Top Holdings

Top Holdings